What type of study is this?

This is a Animal Study study (also classified as: Observational).

September 10, 2025Open Access

Combination of 20(R)-Rg3 and HUCMSCs Alleviates Type 2 Diabetes Mellitus in C57BL/6 Mice by Activating the PI3K/Akt Signaling Pathway

View Full Paper

Ask AI

Bookmark

Authors

Combination therapy reduces insulin resistance and hyperglycemia in mice with type 2 diabetes, highlighting the role of HUCMSCs and 20(R)-Rg3.

The combination of 20(R)-Rg3 and HUCMSCs remarkably reduces hyperglycemia and improves insulin sensitivity.
In diabetic mice, the combination therapy showed greater efficacy than HUCMSCs alone, improving glycemic control.
Analysis included assessments of blood glucose, insulin resistance, and histopathological evaluations of major organs.
Activation of the PI3K/Akt signaling pathway is identified as the main mechanism mediating the therapeutic effects.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 10, 2025Open Access

View Full Paper

Ask AI

Bookmark

Authors

Combination therapy reduces insulin resistance and hyperglycemia in mice with type 2 diabetes, highlighting the role of HUCMSCs and 20(R)-Rg3.

The combination of 20(R)-Rg3 and HUCMSCs remarkably reduces hyperglycemia and improves insulin sensitivity.
In diabetic mice, the combination therapy showed greater efficacy than HUCMSCs alone, improving glycemic control.
Analysis included assessments of blood glucose, insulin resistance, and histopathological evaluations of major organs.
Activation of the PI3K/Akt signaling pathway is identified as the main mechanism mediating the therapeutic effects.

Zhou et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark